X0306 4 2018-04-02 0 0000884624 ORTHOFIX INTERNATIONAL N V OFIX 0001669839 NIEMANN BRADLEY V. 3451 PLANO PKWY LEWISVILLE TX 75056 0 1 0 0 President Biostim Common Stock 2018-04-02 4 A 0 2528 0.00 A 21296 D Stock Option (right to buy) 56.87 2018-04-02 4 A 0 8973 0.00 A 2028-04-02 Common Stock 8973 8973 D Performance Share Units 0.00 2018-04-02 4 A 0 5055 0.00 A 2021-04-02 Common Stock 5055 5055 D Represents time-based vesting restricted stock that vests in 25% increments on the first, second, third and fourth anniversaries of the grant date, April 2, 2018. These stock options vest in 25% increments on the first, second, third and fourth anniversaries of the grant date, April 2, 2018. Represents market-based vesting performance stock units ("PSUs") that will settle as common stock on a one-for-one basis. The performance period of the grant is defined as April 2, 2018 to April 2, 2021. The PSUs will vest based on the percentile rank of the Company's total shareholder return ("TSR") over the performance period in relation to the TSR of the specified index companies. The index companies are based upon the companies included within the S&P Healthcare Select Sector index as of April 2, 2018, the grant date. In the event that the Company's TSR ranks at the 75th percentile or greater for the performance period, 200% of the PSUs will vest. In the event that the Company's TSR ranks between the 50th percentile and the 75th percentile, 100-200% of the PSUs will vest and 50-100% of the PSUs will vest if the Company's TSR ranks between the 25th percentile and 50th percentile. No PSUs will vest if the Company ranks below the 25th percentile. /s/ Kimberley A. Elting, Chief Legal and Administrative Officer, by power of attorney 2018-04-03